See more : AltEnergy Acquisition Corp. (AEAEW) Income Statement Analysis – Financial Results
Complete financial analysis of Bright Health Group, Inc. (BHG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bright Health Group, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Ryoden Corporation (8084.T) Income Statement Analysis – Financial Results
- Applied Molecular Transport Inc. (AMTI) Income Statement Analysis – Financial Results
- G&P Acquisition Corp. (GAPAU) Income Statement Analysis – Financial Results
- Altamira Gold Corp. (ALTA.V) Income Statement Analysis – Financial Results
- NIO Inc. (9866.HK) Income Statement Analysis – Financial Results
Bright Health Group, Inc. (BHG)
About Bright Health Group, Inc.
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics. As of December 31, 2021, it worked with approximately 260,000 care provider partners; and operated 180 managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers commercial and medicare health plan products to consumers in 14 states and 99 markets. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 2.41B | 4.03B | 1.21B | 280.67M | 130.63M |
| Cost of Revenue | 1.28B | 2.21B | 3.95B | 1.05B | 224.39M | 96.41M |
| Gross Profit | -122.92M | 205.79M | 75.72M | 160.02M | 56.29M | 34.23M |
| Gross Profit Ratio | -10.59% | 8.53% | 1.88% | 13.25% | 20.05% | 26.20% |
| Research & Development | 0.00 | 0.00 | 0.00 | 19.43M | 7.24M | 2.54M |
| General & Administrative | 0.00 | 501.84M | 626.36M | 211.75M | 104.22M | 54.48M |
| Selling & Marketing | 0.00 | 82.34M | 287.76M | 96.94M | 49.71M | 26.75M |
| SG&A | 0.00 | 584.18M | 914.11M | 308.69M | 153.93M | 81.23M |
| Other Expenses | 1.74B | 98.28M | 359.76M | 89.50M | 20.45M | 13.09M |
| Operating Expenses | 1.74B | 682.46M | 1.27B | 417.62M | 181.62M | 96.87M |
| Cost & Expenses | 3.02B | 2.89B | 5.23B | 1.46B | 406.01M | 193.27M |
| Interest Income | 0.00 | 12.82M | 7.23M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 38.20M | 12.82M | 7.96M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 24.17M | 51.36M | 36.71M | 8.29M | 1.13M | 1.03M |
| EBITDA | -1.15B | -425.31M | -1.16B | -249.31M | -124.20M | -61.61M |
| EBITDA Ratio | -98.68% | -17.63% | -28.82% | -20.65% | -44.25% | -47.16% |
| Operating Income | -627.74M | -476.67M | -1.20B | -257.60M | -125.34M | -62.64M |
| Operating Income Ratio | -54.08% | -19.76% | -29.74% | -21.34% | -44.66% | -47.95% |
| Total Other Income/Expenses | -1.43M | -157.61M | -861.96M | -3.80M | 0.00 | 0.00 |
| Income Before Tax | -629.17M | -634.29M | -1.20B | -257.60M | -125.34M | -62.64M |
| Income Before Tax Ratio | -54.20% | -26.30% | -29.90% | -21.34% | -44.66% | -47.95% |
| Income Tax Expense | -1.43M | 3.68M | -26.52M | -9.16M | 8.35M | 3.51M |
| Net Income | -1.20B | -637.97M | -1.18B | -248.44M | -133.69M | -62.64M |
| Net Income Ratio | -103.43% | -26.45% | -29.24% | -20.58% | -47.63% | -47.95% |
| EPS | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| EPS Diluted | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| Weighted Avg Shares Out | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
| Weighted Avg Shares Out (Dil) | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
Bright Health Group, Inc. (BHG) Q2 2023 Earnings Call Transcript
Bright Health Group (BHG) Reports Q2 Loss, Lags Revenue Estimates
Bright Health Group Reports Second Quarter 2023 Results
Bright Health Group Secures Financing to Support Operations Pending the Expected Close of California Medicare Advantage Business Sale
Bright Health Group to Host Second Quarter 2023 Earnings Conference Call on August 9, 2023
Molina Healthcare acquisition of Bright Health assets ‘significant' for achieving premium target: broker
Strength Seen in Bright Health (BHG): Can Its 11.9% Jump Turn into More Strength?
Molina Healthcare announces a $600 million deal with Bright Health
Molina Healthcare to buy Bright Health Group's California Medicare business
Finding Breakout Penny Stocks to Buy; 3 Tips to Use
Source: https://incomestatements.info
Category: Stock Reports